CEVEC
CEVEC focuses on the development of a platform expression technology based on specific human cell lines (CAP cell lines) and on the development of selected biopharmaceuticals.CEVEC was founded in 2001 by a group of internationally renowned scientists and clinicians from the University of Cologne. Based on their experience and their longstanding collaborative work they had experienced a lack of innovative expression systems for more efficient production of biologics such as recombinant proteins or gene therapy vectors.
| Type: | NORMAL |
| Address: | Gottfried-Hagen Str. 62 D-51105 Köln |
| Website: | www.cevec-pharmaceuticals.com |
| Phone: | +49 (0)2 21- 46 02 08 00 |
| Email: | lichtenberger@cevec-pharmaceuticals.com |